Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 28 min ago
PreprintCC BY-NC-NDbioRxiv

Disruption of R2TP-mediated PIKK maturation with de novo designed binders

2 more authors
  1. 1Spanish National Cancer Research Centre (CNIO), Structural Biology Programme, Melchor Fernandez Almagro 3, 28029 Madrid, Spain

Abstract

Phosphatidylinositol 3-kinase-related kinases (PIKKs), including ATM, ATR, DNA-PKcs, SMG1, TRRAP and mTOR, are regulators of gene expression, DNA damage response and metabolism. Their maturation depends on R2TP, a co-chaperone complex comprising the RUVBL1/2 AAA+ ATPase, RPAP3 and PIH1D1. While small-molecule RUVBL1/2 inhibitors have shown promise in cancer models, the presence of RUVBL1/2 in other complexes raises concerns about specificity. Here, we identified the RUVBL1/2-RPAP3 interface as a vulnerability, exploiting it using de novo designed protein binders that occupy the RPAP3-binding site. These subnanomolar-affinity binders dismantle R2TP, depleting levels of all PIKKs while sparing other RUVBL1/2-containing complexes, including chromatin remodelers INO80, SRCAP and TIP60. CryoEM, proteomic, biochemical and cellular analyses revealed that these binders outcompete RPAP3, trapping RUVBL1/2 in a catalytically inactive conformation. Our findings establish selective disruption of R2TP by artificial proteins as a strategy to control PIKK abundance.

Related

  1. A rapid, automation-friendly, cell-free and purification-free pipeline for binding and kinetic characterisation of de novo designed binders with high quality standardised per-design data
    D. Ruiz Espi, G. Avelar Molina, O. Sonne Buch +9
    bioRxivPreprintCC BYFull textMolecular biology & gene regulationbioRxiv
  2. Quantitative analysis of proteostasis disruption following siRNA-mediated HSP70 depletion in HeLa cells
    Hatice Esenkaya
    Frontiers in geneticsPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  3. PslG-Mediated Disruption of Pseudomonas aeruginosa Biofilms: A Multi-Omics Investigation of Matrix Glycan Release, Metabolic Reprogramming, and Structural Disintegration
    Yaqian Zheng, Zebin Gui, Yun Xue +5
    International journal of molecular sciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCCrossref
  4. MYC targeted de novo binders impair tumor growth
    N. K. McNamara-Bordewick, K. Wu, Y. Su +7
    bioRxivPreprintCC BYFull text1 citedMolecular biology & gene regulationbioRxiv
  5. Crowdsourcing functional cell therapy binders from generative artificial intelligence
    Abdul Vehab Dozic, Caleb A Lareau
    Molecular Systems BiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefPMC
BibTeX
@misc{gonzalezrodriguez2026disruption,
  title = {{Disruption of R2TP-mediated PIKK maturation with de novo designed binders}},
  author = {N. Gonzalez-Rodriguez and A. Lopez-Perrote and C. Reglero and J. Alegrio-Louro and M. Failde-Soler and C. Chacon-Sanchez and E. Blanco-Romero and E. Casajus-Pelegay and G. Lopez-Pernas and I. Hernandez and M. Murga and O. Fernandez-Capetillo and O. Llorca and R. Fernandez-Leiro},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.26.761954},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.26.761954v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Disruption of R2TP-mediated PIKK maturation with de novo designed binders
AU  - N. Gonzalez-Rodriguez
AU  - A. Lopez-Perrote
AU  - C. Reglero
AU  - J. Alegrio-Louro
AU  - M. Failde-Soler
AU  - C. Chacon-Sanchez
AU  - E. Blanco-Romero
AU  - E. Casajus-Pelegay
AU  - G. Lopez-Pernas
AU  - I. Hernandez
AU  - M. Murga
AU  - O. Fernandez-Capetillo
AU  - O. Llorca
AU  - R. Fernandez-Leiro
PY  - 2026
DA  - 2026/10/26
PB  - bioRxiv
DO  - 10.64898/2026.10.26.761954
UR  - https://www.biorxiv.org/content/10.64898/2026.10.26.761954v1
AB  - Phosphatidylinositol 3-kinase-related kinases (PIKKs), including ATM, ATR, DNA-PKcs, SMG1, TRRAP and mTOR, are regulators of gene expression, DNA damage response and metabolism. Their maturation depends on R2TP, a co-chaperone complex comprising the RUVBL1/2 AAA+ ATPase, RPAP3 and PIH1D1. While small-molecule RUVBL1/2 inhibitors have shown promise in cancer models, the presence of RUVBL1/2 in other complexes raises concerns about specificity. Here, we identified the RUVBL1/2-RPAP3 interface as a vulnerability, exploiting it using de novo designed protein binders that occupy the RPAP3-binding site. These subnanomolar-affinity binders dismantle R2TP, depleting levels of all PIKKs while sparing other RUVBL1/2-containing complexes, including chromatin remodelers INO80, SRCAP and TIP60. CryoEM, proteomic, biochemical and cellular analyses revealed that these binders outcompete RPAP3, trapping RUVBL1/2 in a catalytically inactive conformation. Our findings establish selective disruption of R2TP by artificial proteins as a strategy to control PIKK abundance.
ER  -